A PET Study With RO5545965 in Healthy Male Volunteers
NCT01923025
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
9
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
RO5545965
Sponsor
Hoffmann-La Roche